SCHEMBL378415

SCHEMBL378415

CCN(C(=O)C1(c2ccc(F)cc2)CCN(C(=O)OC(C)(C)C)CC1)c1ccc(F)cc1

nearest known ligand 0.45

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.45
KMT2A Q03164 1/20 0.45
TSHR P16473 2/20 0.43
ALOX15 P16050 1/20 0.43
ATM Q13315 1/20 0.43
RORC P51449 5/20 0.43
OPRM1 P35372 1/20 0.42
HDAC2 Q92769 2/20 0.41
HDAC1 Q13547 1/20 0.41
HSD11B1 P28845 1/20 0.40
JAK2 O60674 1/20 0.39
JAK1 P23458 1/20 0.39
TACR1 P25103 1/20 0.39
CNR1 P21554 1/20 0.39
CNR2 P34972 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2473051 0.84 TSHR (0.49) KMT2ATSHRALOX15ATMTACR1
SCHEMBL2466715 0.81 MEN1 (0.42) MEN1KMT2ARORCHDAC2HDAC1
SCHEMBL396197 0.81 TSHR (0.53) MEN1KMT2ATSHRALOX15ATM
SCHEMBL4036612 0.79 MEN1 (0.46) MEN1KMT2ATSHRALOX15ATM
SCHEMBL31382020 0.78 TSHR (0.51) MEN1KMT2ATSHRALOX15ATM
SCHEMBL378699 0.78 OPRM1 (0.43) MEN1KMT2ATSHROPRM1HSD11B1
SCHEMBL6543160 0.77 TSHR (0.57) TSHRALOX15ATMOPRM1TACR1
SCHEMBL2472784 0.76 TSHR (0.50) MEN1KMT2ATSHRALOX15ATM
SCHEMBL3264110 0.76 RORC (0.49) MEN1KMT2ATSHRALOX15ATM
SCHEMBL3266179 0.75 RORC (0.51) MEN1KMT2ARORCHDAC2HDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2408745-A1 PIPERIDINE DERIVATIVES AS NK3 RECEPTOR ANTAGONISTS F. Hoffmann-La Roche AG (CH) 2012-01-25 EP disclosed
WO-2010106081-A1 PIPERIDINE DERIVATIVES AS NK3 RECEPTOR ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2010-09-23 WO disclosed